These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6972089)

  • 1. Thymus cells suppress the in vitro cytotoxic response against trinitrophenyl (TNP) modified syngeneic cells.
    Hurme M; Bång BE
    Scand J Immunol; 1981; 13(1):35-40. PubMed ID: 6972089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cells distinguish between trinitrophenyl- and dinitrophenyl-modified syngeneic cells.
    Forman J
    J Exp Med; 1977 Aug; 146(2):600-5. PubMed ID: 69006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different characteristics of allogeneic and trinitrophenyl-modified H-2-restricted cell-mediated lympholysis: analysis of differences in interleukin-2 dependency using an ontogenical approach.
    Gondo H; Tokuda N; Tanaka K; Nomoto K
    Cell Immunol; 1986 Jul; 100(2):422-33. PubMed ID: 2944606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.
    Schmitt-Verhulst AM; Pettinelli CB; Henkart PA; Lunney JK; Shearer GM
    J Exp Med; 1978 Feb; 147(2):352-68. PubMed ID: 75237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
    Forman J
    J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
    Fujiwara H; Levy RB; Shearer GM
    Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
    Wolos JA; Smith JB
    J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.
    Wilson DB; Lindahl KF; Wilson DH; Sprent J
    J Exp Med; 1977 Aug; 146(2):361-7. PubMed ID: 301550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes.
    Takatsu K; Kikuchi Y; Kanatani T; Okuno K; Hamaoka T; Tominaga A; Sano Y
    J Immunol; 1986 Feb; 136(4):1161-70. PubMed ID: 3080519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clonal analysis of cytotoxic lymphocytes against 2,4,6-trinitrophenyl (TNP)-modified cells.
    Ching LM; Marbrook J
    Eur J Immunol; 1979 Jan; 9(1):22-7. PubMed ID: 86448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell types required for H-2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic cells or trinitrophenyl-conjugated proteins.
    Pettinelli CB; Schmitt-Verhulst AM; Shearer GM
    J Immunol; 1979 Mar; 122(3):847-54. PubMed ID: 87418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of helper T cells and suppressor T cells that regulate the cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells.
    Gualde N; Weinberger O; Ratnofsky S; Benacerraf B; Burakoff SJ
    Transplantation; 1982 Apr; 33(4):422-6. PubMed ID: 6461956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secondary cytotoxic response to trinitrophenyl (TNP) modified syngeneic lymphocytes: effectors generated in vitro differ from those generated in vivo.
    Tagart V
    Scand J Immunol; 1978; 8(2):91-7. PubMed ID: 705261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared determinants between virus-infected and trinitrophenyl-conjugated H-2-identical target cells detected in cell-mediated lympholysis.
    Starzinski-Powitz A; Pfizenmaier K; Koszinowski U; Röllinghoff M; Wagner H
    Eur J Immunol; 1976 Sep; 6(9):630-4. PubMed ID: 63379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells.
    Finberg R; Burakoff SJ; Benacerraf B; Greene MI
    J Immunol; 1979 Sep; 123(3):1210-4. PubMed ID: 89165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymphocytes.
    Grimm EA; Wilson DJ
    Cell Immunol; 1985 Sep; 94(2):568-78. PubMed ID: 3928175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells.
    Finberg R; Greene MI; Benacerraf B; Burakoff SJ
    J Immunol; 1979 Sep; 123(3):1205-9. PubMed ID: 89164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.
    Burakoff SJ; Germain RN; Benacerraf B
    J Exp Med; 1976 Dec; 144(6):1609-20. PubMed ID: 1087327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
    Gillette RW; Berringer DC; Wunderlich DA
    J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.